4.5 Article

Proteinuria is a determinant of quality of life in diabetic nephropathy: Modeling lagged effects with path analysis

期刊

AMERICAN JOURNAL OF NEPHROLOGY
卷 27, 期 5, 页码 488-494

出版社

KARGER
DOI: 10.1159/000106672

关键词

chronic kidney disease; diabetic nephropathy, quality of life; end-stage renal disease; glipizide; kidney disease burden; mental component score; physical component score; pioglitazone; proteinuria; type 2 diabetes mellitus; path analysis

向作者/读者索取更多资源

Background: Diabetic nephropathy with overt proteinuria often progresses relentlessly to end-stage renal disease ( ESRD). Material and Methods: To answer the question whether it is impaired glomerular filtration rate (GFR) or its precursor proteinuria which is more related with multiple domains of health-related quality of life (HRQOL), we measured GFR and proteinuria in 44 patients with type 2 diabetes and overt nephropathy and repeated the measurements after 4 months. 38 patients with ESRD due to diabetic nephropathy served as a control group. We used path analysis to examine the association of baseline proteinuria and GFR with baseline and subsequent HRQOL scales. Results: Compared to patients with ESRD, patients with non-dialysis CKD had Kidney Disease Burden (KDB) that was, on a scale from 0 to 100, 19.8 better (95% Cl 6.9-32.8) (p = 0.003). Mental component score (MCS) did not differ and physical component score (PCS) was worse in non-dialysis CKD patients by 8.5 (p < 0.001). Proteinuria at baseline was a predictor of PCS, MCS and KDB score at 4 months, suggesting a lagged effect of proteinuria on HRQOL after controlling for the autoregressive effects. GFR was not shown to have a significant impact on HRQOL. One log unit increase in proteinuria was associated with 3.8 (p = 0.011) fall in PCS, 3.3 (p = 0.043) fall in MCS and 10.6 (p = 0.006) fall in KDB. Conclusion: In patients with advanced diabetic nephropathy, we found that proteinuria has a lagged and profound effect on multiple domains of HRQOL. Copyright (c) 2007 S. Karger AG, Basel.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据